| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
| Address |
404-10,NOJANG-RI, JEONDONG-MYEON, YEONGI-GUN, CHUNGNAM |
| Home Page |
www.kup.co.kr
|
| Established |
1987.12. 3 |
Tel |
041-862-5030 |
| Listed |
2007.10.23 |
IR |
02-516-3041 |
| Common shares O/S |
15,025,924 |
President |
Kang,Duk Young |
| Preferred shares O/S |
|
No.of Employees |
618(2009. 9) |
| Sales jumped on increased sales of its key products and new products such as blood pressure-lowering medicine. Profitability improved on falling fixed costs and rising demand for high-priced products. The company beefed up its production line-ups through continued research and development. |
| The company is seeking to increase sales of high-priced products, thus boosting profitability. Profitability is expected to improve on falling costs and low administrative costs. Its market domination is expected to increase on rising demand for new products such as arthritis medicine. |
|
  |
(date: 2009.06, unit : %) |
| Name |
Kang Deogyeong |
Kang Wonho |
Kang Gwija |
| Portion |
41.3 |
3.3 |
0.7 |
|
 |
(unit : %) |
| Sales |
Antibiotics |
30.1 |
Cost |
Raw Materials |
|
| Gastrointestinal System Drugs |
13.5 |
Labors |
|
| Others |
20.9 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
07.10 |
- |
- |
- |
- |
| Type |
LI |
- |
- |
- |
- |
| Amount |
75.13 |
- |
- |
- |
- |
|
|
|
|
